Changeflow GovPing Pharma & Drug Safety Bright Light Treatment for Cognitive Impairment...
Routine Notice Added Final

Bright Light Treatment for Cognitive Impairment in Major Depressive Disorder

Favicon for clinicaltrials.gov ClinicalTrials.gov
Detected
Email

Summary

ClinicalTrials.gov registered a new interventional study (NCT07508215) conducted by Peking University investigating bright light treatment for cognitive impairment in patients with Major Depressive Disorder. The study appears to be a clinical trial evaluating non-pharmacological therapeutic interventions. No regulatory action or compliance requirements are associated with this registration notice.

What changed

This is a clinical trial registration on ClinicalTrials.gov for a study titled 'Bright Light Treatment, Cognitive Impairment, Major Depressive Disorder' sponsored by Peking University. The trial studies the use of bright light therapy as an intervention for cognitive impairment associated with Major Depressive Disorder. NCT07508215 is the assigned registry identifier.

This is a routine clinical trial registration notice. No compliance deadlines, penalties, or required actions apply to regulated entities. Clinical investigators and healthcare providers may review the trial details on ClinicalTrials.gov for awareness of ongoing research in this therapeutic area. Trial sponsors conducting applicable clinical trials should continue to ensure proper registration compliance under FDA regulations.

Archived snapshot

Apr 3, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Show glossary

Named provisions

Bright Light Treatment Study Details Major Depressive Disorder Intervention Trial

Get daily alerts for ClinicalTrials.gov

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NLM.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
NLM
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
NCT07508215

Who this affects

Applies to
Clinical investigators Healthcare providers Patients
Industry sector
6211 Healthcare Providers 6221 Hospitals & Health Systems
Activity scope
Clinical Trial Registration Psychiatric Research
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Pharmaceuticals Clinical Operations

Get alerts for this source

We'll email you when ClinicalTrials.gov publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.